about
Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.Are hemoglobin levels elevated in type 1 diabetes?Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study.Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study.Improving employee health: evaluation of a worksite lifestyle change program to decrease risk factors for diabetes and cardiovascular disease.Predicting major outcomes in type 1 diabetes: a model development and validation studyWhite matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetesPulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 DiabetesCaffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 DiabetesTest characteristics of the ankle-brachial index and ankle-brachial difference for medial arterial calcification on X-ray in type 1 diabetesEvaluation of non-invasive screening measures to identify individuals with prediabetes.Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Predictors of and survival after incident stroke in type 1 diabetesMultiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicatPhysical Activity Levels in a Community Lifestyle Intervention: A Randomized TrialType A behavior and risk of all-cause mortality, CAD, and CAD-related mortality in a type 1 diabetic population: 22 years of follow-up in the Pittsburgh Epidemiology of Diabetes Complications StudyFrontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complicationsChanging impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study.Prediction of proliferative diabetic retinopathy with hemoglobin level.Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study.Perceptions of safety culture vary across the intensive care units of a single institution.Evaluation of a community Diabetes Prevention Program delivered by diabetes educators in the United States: one-year follow up.Impact of a community-based lifestyle intervention program on health-related quality of life.Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.Hemoglobin A1c and Cardiovascular Disease Incidence in Type 1 Diabetes: An Application Of Joint Modeling Of Longitudinal And Time-To-Event Data In The Pittsburgh Epidemiology Of Diabetes Complications (EDC) Study.Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.A novel approach to diabetes prevention: evaluation of the Group Lifestyle Balance program delivered via DVD.Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetes.Risk Factor Modeling for Cardiovascular Disease in Type I Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison to the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicatOlder age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications StudyUnderstanding Metabolic Memory: A Tale of Two StudiesClostridium difficile infections in outpatient dialysis cohort
P50
Q33400921-58679711-F575-42E4-86E7-24A13AB52392Q33602249-802C1F36-2B8C-487B-849A-BE9958FF7C19Q33805731-D561DA24-6B64-4CC1-A94B-04312606BBA0Q33835519-9F0010E0-CCF8-41C3-9882-896938083225Q34382202-39876A4A-E3C2-44BA-94FE-66230B10E309Q34641067-AC2758F7-BACB-4D30-B80A-0D7DB2C8B86DQ34762641-D1B62904-F17D-4736-8E1B-EBEEC63B5726Q34815418-E911FA65-0782-439B-856B-C1978BB8E131Q35154005-BF32E8DB-6F96-40EF-804E-C0AFE7B82CC2Q35446651-A745F435-0D4F-4E36-88A9-40FF46D6A6B7Q35639973-90D69524-477C-476F-9413-6C1382670D45Q35686583-F0B0F5E5-6A58-43FC-B9FD-50B4AD3753D3Q35973261-B5861EE5-B421-4467-8F39-7A03DA817E1CQ36074058-7F95F168-CD45-47E5-AD0D-5FAFF7E9C6BCQ36152961-1588D4C3-0997-462E-A1F8-2D2F0B8ACB5EQ36561387-0BACE314-73D5-43D9-894F-615B7A3F7C79Q36782847-6358B919-26B7-4EF8-AD3E-7695D25BB0D5Q36793264-5370DE0D-51C4-4386-B337-AB1952A8E555Q37127488-C0C06429-2664-4F4C-94D3-E63D8D8B3DE9Q37191079-11E8571D-B1CA-4C13-BF51-2030848E1133Q37193490-ACB22714-AE12-4358-B170-615857A5EC98Q37281771-59BB623E-B7D9-42EA-ADB2-98CB857FA151Q37331337-D08A30A8-258A-49A4-B43E-A9AB84D35DFFQ37423520-ED6E60C3-7CD0-4FE4-AD87-A37F03C6A3ACQ37711215-D8D24C99-E1AC-42ED-BA81-26FD44A5C741Q37731747-4BAB41C3-CB52-4AB8-96CE-8F3414941A0DQ38666896-636FFB25-1916-4C21-8D21-B3CB80C39B53Q39365246-B42B6BEC-EDDE-4F7F-8412-03396B5AD316Q39775174-180F8CD9-051B-41AA-BB14-703C8B1BC041Q40240862-13912FFE-B0D0-4348-BDE3-1BF278215501Q40898298-E9461179-FF04-46BC-AA96-35304F3283DAQ43234279-919318E2-5EE0-4DA7-9F56-887F39C066CFQ49372861-2AECC3AA-6731-453E-ACFE-70FA426BD66BQ49794561-EDCAF7D5-BDA8-4ABD-813D-13E5F3892DF6Q51750905-1C6FD3A6-547E-4A93-AADA-6CD1627367B9Q53444724-2D609E3F-C9DC-4623-A1CF-C0A3A35AA21BQ58578856-7E59AE92-234B-472E-91E0-F40A8A947A46Q89499530-474EBFDD-0575-4D50-8223-11D603AD88D8Q89808232-25677A6B-67B2-4AE3-AAC5-98CB7A51496AQ94946381-6C0BCAFF-5521-4D25-B556-1B110324633D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rachel Miller
@ast
Rachel Miller
@en
Rachel Miller
@es
Rachel Miller
@nl
type
label
Rachel Miller
@ast
Rachel Miller
@en
Rachel Miller
@es
Rachel Miller
@nl
prefLabel
Rachel Miller
@ast
Rachel Miller
@en
Rachel Miller
@es
Rachel Miller
@nl
P106
P21
P31
P496
0000-0003-1845-8477